Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Clinical study on early post-operational intraperitoneal chemotherapy and salviae in treating patients of gastric cancer
  
View Full Text  View/Add Comment  Download reader
KeyWord:gastric cancer, post operational stage, intraperitoneal chemotherapy, Radix Salviae Miltiorrhizae, 5 Fluorouracil
Author NameAffiliation
Qing-sheng Yu Department of Surgery, the First Affiliated Hospital of Anhui College of Traditional Chinese Medicine, (230031), Hefei 
Wei Wang Department of Surgery, the First Affiliated Hospital of Anhui College of Traditional Chinese Medicine, (230031), Hefei 
Xiao-ming Wang Department of Surgery, the First Affiliated Hospital of Anhui College of Traditional Chinese Medicine, (230031), Hefei 
Han-ming Wang Department of Surgery, the First Affiliated Hospital of Anhui College of Traditional Chinese Medicine, (230031), Hefei 
Jian-feng Shuai Department of Surgery, the First Affiliated Hospital of Anhui College of Traditional Chinese Medicine, (230031), Hefei 
Hits: 1038
Download times: 550
Abstract:
      Objective: To evaluate the safety, feasibility and short term efficacy of early post operational intraperitoneal chemotherapy (EPIC) combined with Salviae miltiorrhizae (SM) in treating patients with gastric cancer. Methods: The 136 patients enrolled were divided into 3 groups: the EPIC group, the EPVC group and the control group. The former two groups were treated with SM plus 5 FU started from the second or third day after operation for 5 continuous days by intraperitoneal infusion or intravenous dripping respectively, and the control group was untreated but conventional chemotherapy was given 3 weeks after surgical operation. Toxic and adverse effects of chemotherapy, post operational complications, short term survival rate and intra abdominal tumor recurrence rate were observed and compared.Results: (1) Toxic adverse effects of chemotherapy that occurred in the EPIC group were less than those in the EPVC group significantly ( P <0.05 0.01). (2) Occurrence of serious complications in the EPIC group was not higher than that in the other two groups. (3) The 1 and 2 year survival rate in the EPIC group was higher than those in the other two groups respectively ( P <0.01), while the post operational intra abdominal recurrence rate in EPIC group was significantly lower than that in the other two groups ( P <0.05). Conclusions: Combined therapy of SM and 5 FU in treating patients with gastric cancer by intraperitoneal infusion is not only safe and feasible with mild toxic and side effect, but also produces a more beneficial effects, including less intra abdominal recurrence and satisfactory short term survival rate .
Close